NINJ2 and colonic neoplasm: Given that oxaliplatin has been reported to stimulate intracellular ROS production [41, 42], the inhibition of ROS generation through NINJ2 gene downregulation might elucidate the resistance to oxaliplatin seen in colon cancer cells.